Profit with us in the 2009 bear market
   

Recent Material Events - Javelin Pharmaceuticals, Inc (JAV)

Filing Date Description
2009-11-10 On November 10, 2009, Javelin Pharmaceuticals, Inc. (the “Company”) reported its financial results for the fiscal quarter ended September 30, 2009. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated here ...
2009-10-30 On October 30, 2009, Javelin Pharmaceuticals, Inc. (the “Company”) entered into a Placement Agency Agreement with Ladenburg Thalmann & Co. Inc. as placement agent (the “Placement Agent”), relating to the proposed registere ...
2009-08-11 On August 11, 2009, Javelin Pharmaceuticals, Inc. (the “Company”) reported its financial results for the fiscal quarter ended June 30, 2009. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by r ...
2009-08-11 On August 11, 2009, Javelin Pharmaceuticals, Inc. issued a press release describing its initial review of top line results from a randomized, multicenter, double-blind, 1:1 placebo-controlled Phase 3 clinical study of Ereska™ (intranasal ketami ...
2009-04-14 Javelin Pharmaceuticals, Inc. has allowed its employment agreement with David B. Bernstein, the Company’s Secretary, General Counsel and Chief Intellectual Property Counsel since April 2006, to expire effective as of April 10, 2009. ...
2009-03-12 On March 12, 2009, Javelin Pharmaceuticals, Inc. (the “Company”) reported its financial results for the fiscal year ended December 31, 2008. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by ref ...
2009-03-03 On January 23, 2009, the Board of Directors (the “Board”) of Javelin Pharmaceuticals, Inc. (the “Company”), upon recommendation of the Compensation Committee, established the following base salaries for the following “named e ...
2008-11-10 On November 10, 2008, Javelin Pharmaceuticals, Inc. (the “Company”) reported its financial results for the quarter ended September 30, 2008. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by ref ...
2008-08-05 On July 30, 2008, Javelin Pharmaceuticals, Inc. (the “Company”) entered into a Development and Toll Manufacturing Agreement (the “Manufacturing Agreement”) with Baxter Healthcare Corporation (“Baxter” ;) for drug supply in ...
2008-06-06 On June 4, 2008, Javelin Pharmaceuticals, Inc. (the “Company”) issued a press release announcing that it was granted a patent in the European Union that extends patent protection for the Company’s PMI-150 (intranasal ketamine) drug can ...
   
 
Home > Companies > Javelin Pharmaceuticals, Inc > Recent Material Events
Home | Message boards | Newsletters | Latest Comments | AIM London Stock Exchange | Canadian stocks | Chinese stocks
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2009 hotstocked.com - All rights reserved.